Search Results - 1121%3b

1 Results Sort By:
Murine Monoclonal Antibodies Effective To Treat Respiratory Syncytial Virus
Available for licensing through a Biological Materials License Agreement are the murine MAbs described in Beeler et al, "Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function," J Virol. 1989 Jul;63(7):2941-2950 (PubMed abs). The MAbs that are available for licensing are the following:...
Published: 10/28/2024   |   Inventor(s): Peter Collins, Kathleen Coelingh, Robert Chanock (Estate), Brian Murphy, Judith Beeler
Keywords(s): #s, 1107;, 1112;, 1121;, 1129;, 1142;, 1153;, 1175-40; 1113-44; 1105-1, 1200;, 1214;, 1269, Cell, DB4BXX, DBXXXX, DXXXXX, Hybridoma, Lines, monoclonal
Category(s): Collaboration Sought > Licensing, Collaboration Sought > Materials Available, Application > Therapeutics, TherapeuticArea > Infectious Disease